Insilico to present its research in AI at BioCentury China Healthcare Summit

(InSilico Medicine, Inc.) The CEO of Insilico Medicine, Alex Zhavoronkov, PhD will present Insilico's latest results in the generation of novel small molecule leads using the Generative Adversarial Networks and Reinforcement Learning, as well as the multi-modal biomarkers of human aging and age-related diseases.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news